Oct 11, 2013 4:54pm EDT Immunovaccine Retains B & D Capital Partners For Strategic Investor Relations Services
Aug 29, 2013 5:05pm EDT Immunovaccine Announces Financial Results for the Quarter Ended June 30, 2013
Aug 02, 2013 9:27am EDT Immunovaccine Secures $5 Million Loan to Support Clinical Stage Cancer Vaccines and DepoVax(TM) Platform
Jul 15, 2013 8:05am EDT Immunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac
Jun 03, 2013 8:05am EDT Immunovaccine Shows Pronounced and Persistent T Cell Immune Responses in DPX-Survivac Cancer Vaccine Study Presented at American Society of Clinical Oncology (ASCO) Meeting
May 30, 2013 8:05am EDT New European Phase II Trial to Test Immunovaccine's DPX-Survivac in Brain Cancer Patients
May 29, 2013 8:05am EDT Immunovaccine to Present Clinical Data on its DPX-Survivac Cancer Vaccine at the 2013 ASCO Annual Meeting
May 16, 2013 5:05pm EDT Immunovaccine Announces Financial Results for the Quarter Ended March 31, 2013
